European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 121, Issue 2 , Pages 211-215 , 1 August 2005

Vaginitis in Turkish women: symptoms, epidemiologic – microbiologic association

Received 13 June 2004 ,Revised 22 October 2004 ,Accepted 30 November 2004.

References 

  1. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985;152:924–935
  2. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol. 1991;165:1168–1176
  3. Sobel JD. Vaginitis. The New Eng J Med. 1997;337:1896–1903
  4. Foxman B, Barlow R, D’Arcy H, Gillespie B, Sobel JD. Candida vaginitis: self-reported incidence and associated costs. Sex Transm Dis. 2000;27:230–235
  5. Sobel JD. Vulvovaginitis, when Candida becomes a problem. Sex Transm Dis. 1998;16:763–768
  6. Catch MF, Hillier SC, Gibbs RS, Eschenbach DA. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Am J Obstet Gynecol. 1998;178:374–380
  7. Pegano R. Vulvar vestibulitis syndrome; an often unrecognized cause of dyspareunia. Aust NZ J Obstet Gynecol. 1999;39:79–83
  8. Hay PE. Bacterial vaginosis and miscarriage. Curr Opin Infect Dis. 2004;17:41–44
  9. Tebes CC, Lynch C, Sinnoth J. The effect of treating Bacterial vaginosis on preterm labor. Infect Dis Obstet Gynecol. 2003;11:123–129
  10. Donders GGG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type abnormal vaginal flora that is distinct from Bacterial vaginosis: aerobic vaginitis. Br J Obstet Gynecol. 2002;109:334–343
  11. Donders GGG. Bacterial vaginosis during pregnancy: screen and treat?. Eur J Obstet Gynecol Reprod Biol. 1999;83:1–4
  12. Amsel R, Totten PA, Spıegel CA, Chien KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Am J Med. 1983;74:14–22
  13. Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, Andrews W. Vulvovaginal symptoms in women with Bacterial vaginosis. Obstet Gynecol. 2004;104:267–272
  14. Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK. Vulvovaginal candidiasis: clinical manifestations, risk factors. Manage Algor Obstet Gynecol. 1998;92:757–765
  15. Nyirjesy P. Chronic vulvovaginal candidiasis. Am Fam Phsician. 2001;102:927–933
  16. Ledger WJ, Monif GRG. A growing concern: inability to diagnose vulvovaginal infections correctly. Obstet Gynecol. 2004;103:782–784
  17. Landers DV, Wiesenfeld HC, Heine RP, Krohn MA, Hillier SL. Predictive value of the clinical diagnosis of lower genital tract infection in women. Am J Obstet Gynecol. 2004;190:1004–1010
  18. Berg AO, Heidrich FE, Fihn SD, Bergman JJ, Wood RW, Stamm WE, et al. Establishing the cause of genitourinary symptoms in women in a family practice. JAMA. 1984;251:620–625
  19. Witkin SS. Immunology of recurrent vaginitis. Am J Reprod Immunol Microbiol. 1987;15:34–37
  20. BV Study GroupHolzman C, Leventhal JM, Qui H, Jones NM, Wang J. Factors linked to Bacterial vaginosis in nonpregnant women. Am J Public Health. 2001;91:1664–1670
  21. Liahi-Camp JR, Rai R, Ison C, Regan L, Taylor-Robinson D. Association of Bacterial vaginosis with a history of second trimester miscarriage. Hum Reprod. 1996;11:1575–1578
  22. Reef SE, Levine WC, McNeil MM, et al. Treatment options for vulvovaginal candidiasis. Clin Infect Dis. 1995;20(Suppl. 1):80–90
  23. Martino JM, Vermund SH. Vaginal douching: evidence for risks or benefits to women health. Epidemiol Rev. 2002;24:109–124
  24. Hodoglugil NN, Aslan D, Bertan M. Intrauterine device use, and some issues related to sexually transmitted disease screening and occurrence. Contraception. 2000;61:359–364
  25. Shoubnikova M, Hellberg D, Nilsson S, Mardh PA. Contraceptive use in women with Bacterial vaginosis. Contraception. 1997;55:355–358

PII: S0301-2115(04)00621-9

doi: 10.1016/j.ejogrb.2004.11.030

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 121, Issue 2 , Pages 211-215 , 1 August 2005

Article Tools